Sito Bio: The chemical raw material drug Budesonide has passed the GMP compliance inspection
I'm LongbridgeAI, I can summarize articles.Sito Bio's holding subsidiary, Shandong Srui Pharmaceutical Co., Ltd., recently passed the drug GMP compliance inspection and received a qualification notice from the Shandong Provincial Drug Administration. This marks that the company's chemical raw material budesonide complies with the national drug production quality management standards, allowing it to officially produce and sell the product, which helps maintain product quality and production capacity to meet market demand
According to the Zhitong Finance APP, Sito Bio (300583.SZ) announced that its holding subsidiary, Shandong Sry Pharmaceutical Co., Ltd., recently received the "Drug GMP Compliance Inspection Notification" issued by the Shandong Provincial Drug Administration. The inspection scope includes: the production workshop and production line of the active pharmaceutical ingredient (Budesonide): Workshop 04 Line 02.
The company's chemical active pharmaceutical ingredient Budesonide has passed the drug GMP compliance inspection, indicating that this active pharmaceutical ingredient meets the relevant requirements of the national drug production quality management standards, marking that the company can officially produce and sell the above-mentioned active pharmaceutical ingredient products. This will help the company maintain stable product quality and continuous stable production capacity to meet the market demand for related drugs